Hamad Medical Corporation (HMC) has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, one of the world’s leading biopharmaceutical companies, to collaborate on initiatives aimed at strengthening clinical research, advancing healthcare
Read more →
